Corcept Therapeutics
CORT
#2480
Rank
ยฃ4.64 B
Marketcap
ยฃ44.37
Share price
-0.30%
Change (1 day)
113.97%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of September 2024 : ยฃ0.30 Billion

According to Corcept Therapeutics 's latest financial reports the company has ยฃ0.30 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ0.28 B-19%
2022-12-31ยฃ0.35 B115.46%
2021-12-31ยฃ0.16 B-48.78%
2020-12-31ยฃ0.32 B53.63%
2019-12-31ยฃ0.21 B29.2%
2018-12-31ยฃ0.16 B148.06%
2017-12-31ยฃ65.66 M57.21%
2016-12-31ยฃ41.76 M53.07%
2015-12-31ยฃ27.28 M75.19%
2014-12-31ยฃ15.57 M-53.19%
2013-12-31ยฃ33.26 M-42.2%
2012-12-31ยฃ57.55 M125.72%
2011-12-31ยฃ25.5 M60.16%
2010-12-31ยฃ15.92 M7.95%
2009-12-31ยฃ14.74 M18.06%
2008-12-31ยฃ12.49 M42.91%
2007-12-31ยฃ8.74 M81.07%
2006-12-31ยฃ4.82 M-71.37%
2005-12-31ยฃ16.86 M-13.44%
2004-12-31ยฃ19.48 M201.01%
2003-12-31ยฃ6.47 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ16.10 B 5,236.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.42 B 2,028.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.12 B 3,586.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ2.79 B 825.08%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.89 B 2,516.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.57 B 3,736.87%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.15 B-50.23%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.19 B-34.86%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.73 B 144.64%๐Ÿ‡บ๐Ÿ‡ธ USA